Trials / Recruiting
RecruitingNCT07014371
Alternative vs. Once-Daily Oral Iron Supplementation in Iron Deficiency Anemia (IDA)
Alternative vs. Once-Daily Oral Iron Supplementation in Iron Deficiency Anemia (IDA): A Multicenter, Randomized, Open-Label, Non-Inferiority Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 114 (estimated)
- Sponsor
- Phramongkutklao College of Medicine and Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to compare the effectiveness and tolerability of two different oral iron regimens in adults with iron deficiency anemia (IDA). The main questions it aims to answer are: Is alternate-day oral iron supplementation as effective as once-daily dosing in improving hemoglobin levels? What are the side effects associated with each dosing regimen? Researchers will compare once-daily vs. alternate-day oral ferrous fumarate to evaluate whether alternate-day dosing is non-inferior in terms of hematologic response, with fewer adverse effects. Participants will: Be randomly assigned to take ferrous fumarate 200 mg once daily or 400 mg on alternate days for 8 weeks Undergo blood tests and clinical assessments at baseline, Week 4, and Week 8 Report any side effects and bring remaining pills to evaluate medication adherence This is a multicenter, randomized, open-label, non-inferiority trial conducted in adults aged 20 years or older with IDA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ferrous Fumarate Oral Tablet | Ferrous fumarate oral tablet 200 mg is an iron supplement used for the treatment of iron deficiency anemia (IDA). In this study, it is administered as either one tablet daily (OD group) or two tablets on alternate days (AD group), with a treatment duration of 8 weeks. The goal is to compare the efficacy and tolerability of alternate-day dosing versus standard once-daily dosing. |
Timeline
- Start date
- 2025-06-09
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
- First posted
- 2025-06-11
- Last updated
- 2026-01-07
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT07014371. Inclusion in this directory is not an endorsement.